Peptide Profiles — 2026-04-14
Semax is a synthetic heptapeptide derived from the ACTH (4-10) sequence. Developed in Russia, it has been studied for decades for its effects on cognition, mood, and neuroprotection — with a particularly strong research base in cerebrovascular and neurological applications.
Semax exerts its effects through multiple converging pathways: - BDNF upregulation — Increases expression of brain-derived neurotrophic factor, critical for neuronal survival and plasticity - NGF modulation — Influences nerve growth factor signaling - Monoaminergic activity — Modulates dopaminergic and serotonergic systems - Enkephalin protection — Inhibits degradation of endogenous opioid peptides - Neuroprotective pathways — Reduces oxidative stress and glutamate excitotoxicity in models of ischemia
Semax is available in research formulations including: - Intranasal spray — The most studied administration route - Injectable — For systemic research applications - Lyophilized powder — For custom formulation
Disclaimer: All information presented in this article is for educational and informational purposes only. Platinum Biolabs does not promote or endorse the use of peptides for human consumption. All products sold by Platinum Biolabs are intended strictly for laboratory and research use only. Consult a qualified healthcare professional before making any health-related decisions.